Kezar Life Sciences, Inc. (KZR)
7.38
+0.04
(+0.54%)
USD |
NASDAQ |
May 06, 16:00
7.38
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences SG&A Expense (TTM) : 18.51M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Apellis Pharmaceuticals, Inc. | 550.26M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.293B |
| Savara, Inc. | 42.06M |
| BioMarin Pharmaceutical, Inc. | 946.91M |